135 related articles for article (PubMed ID: 6370867)
1. Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes.
Pierce NF; Sacci JB
Infect Immun; 1984 May; 44(2):469-73. PubMed ID: 6370867
[TBL] [Abstract][Full Text] [Related]
2. Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.
Pierce NF
Infect Immun; 1984 Jan; 43(1):341-6. PubMed ID: 6606625
[TBL] [Abstract][Full Text] [Related]
3. Enhanced murine respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (avridine).
Bergmann KC; Waldman RH
Int Arch Allergy Appl Immunol; 1988; 87(3):334-5. PubMed ID: 3203969
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin.
Pierce NF; Sacci JB; Alving CR; Richardson EC
Rev Infect Dis; 1984; 6(4):563-6. PubMed ID: 6474016
[TBL] [Abstract][Full Text] [Related]
5. Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.
Pierce NF; Cray WC; Sacci JB; Craig JP; Germanier R; Fürer E
Infect Immun; 1983 Jun; 40(3):1112-8. PubMed ID: 6602094
[TBL] [Abstract][Full Text] [Related]
6. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
Lycke N; Holmgren J
Immunology; 1986 Oct; 59(2):301-8. PubMed ID: 3021614
[TBL] [Abstract][Full Text] [Related]
7. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats.
Pierce NF; Koster FT
J Immunol; 1980 Jan; 124(1):307-11. PubMed ID: 6965294
[TBL] [Abstract][Full Text] [Related]
8. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes.
Zhou F; Kraehenbuhl JP; Neutra MR
Vaccine; 1995 May; 13(7):637-44. PubMed ID: 7668033
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of lymphocyte blastogenesis and neutrophil function by avridine in dexamethasone-treated and nontreated cattle.
Roth JA; Kaeberle ML
Am J Vet Res; 1985 Jan; 46(1):53-7. PubMed ID: 3970443
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of avridine as an adjuvant for Newcastle disease virus antigen in chickens.
Rweyemamu MM; Umehara O; de Lucca-Neto D; Baltazar MC; Vicente FE; Medeiros-Neto Rda R
Am J Vet Res; 1986 Jun; 47(6):1243-8. PubMed ID: 3729124
[TBL] [Abstract][Full Text] [Related]
11. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.
Vajdy M; Lycke NY
Immunology; 1992 Mar; 75(3):488-92. PubMed ID: 1572696
[TBL] [Abstract][Full Text] [Related]
12. Protection of guinea pigs against local and systemic foot-and-mouth disease after administration of synthetic lipid amine (Avridine) liposomes.
Knudsen RC; Card DM; Hoffman WW
Antiviral Res; 1986 Mar; 6(2):123-33. PubMed ID: 3010856
[TBL] [Abstract][Full Text] [Related]
13. Effect of Avridine on enteric antigen uptake and mucosal immunity to reovirus (1/Lang).
Anderson AO; Rubin DH
Adv Exp Med Biol; 1985; 186():579-90. PubMed ID: 4050592
[No Abstract] [Full Text] [Related]
14. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
15. Studies on anti-viral mucosal immunity with the lipoidal amine adjuvant avridine.
Anderson AO; Wood OL; King AD; Stephenson EH
Adv Exp Med Biol; 1987; 216B():1781-90. PubMed ID: 3425462
[No Abstract] [Full Text] [Related]
16. Traffic of antibody-secreting cells after immunization with a liposome-associated, CpG-ODN-adjuvanted oral cholera vaccine.
Somroop S; Tongtawe P; Chaisri U; Tapchaisri P; Chongsa-nguan M; Srimanote P; Chaicumpa W
Asian Pac J Allergy Immunol; 2006 Dec; 24(4):229-38. PubMed ID: 17348246
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antibody response of turkeys to trivalent avian influenza vaccine by positively charged liposomal avridine adjuvant.
Fatunmbi OO; Newman JA; Sivanandan V; Halvorson DA
Vaccine; 1992; 10(9):623-6. PubMed ID: 1502840
[TBL] [Abstract][Full Text] [Related]
18. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.
Jackson RJ; Fujihashi K; Xu-Amano J; Kiyono H; Elson CO; McGhee JR
Infect Immun; 1993 Oct; 61(10):4272-9. PubMed ID: 8406816
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
Harokopakis E; Hajishengallis G; Michalek SM
Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
[TBL] [Abstract][Full Text] [Related]
20. Avridine-induced arthritis in rats; a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes.
Vingsbo C; Jonsson R; Holmdahl R
Clin Exp Immunol; 1995 Mar; 99(3):359-63. PubMed ID: 7882557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
